At a glance

Skin pigmentation / tanning
Appetite suppression
Sexual arousal enhancement
Anti-inflammatory activity
Melanoma / mole-change risk
Nausea / flushing
Cardiovascular / blood-pressure risk
Unregulated product / contamination risk
BenefitSide effectHealth risk· more & brighter bars = stronger

Effects

  • Skin pigmentation / tanning: Stimulates melanin production in skin melanocytes via MC1R, producing progressive skin darkening without UV exposure [1].
  • Appetite suppression: Acts on MC3R/MC4R neurons in the hypothalamic arcuate nucleus to reduce food intake and raise energy expenditure [5].
  • Sexual arousal: α-MSH acts on MC3R and MC4R in the hypothalamus and brain regions to activate central sexual arousal pathways [7].
  • Anti-inflammatory / immunomodulatory: Suppresses pro-inflammatory mediator gene transcription and modulates innate immune-cell activity via MC1R–cAMP signalling [6].
  • Thermoregulation: Influences body temperature regulation via central melanocortin pathways; high doses in animal studies caused significant reductions in body temperature [8].
Classification

Peptide hormone / melanocortin

Active half-life

~1–25 min (biphasic; native form)

Route

Subcutaneous injection (analogues); intranasal (research)

Regulatory status

Not approved for general use; analogues banned by FDA

Approved analogue

Afamelanotide (Scenesse) — EPP only